Holen Sie sich die Stockscreener-App
163.02
2.89%
4.58
Handel nachbörslich:
162.75
-0.27
-0.17%
Natera Inc Aktie (NTRA) Neueste Nachrichten
Natera (NTRA) Is Up 7.3% After Launching Fetal Focus and Raising 2025 Revenue Guidance - simplywall.st
What is Natera Inc. s revenue forecastQuarterly Portfolio Summary & Weekly Top Stock Performers List - thegnnews.com
Natera president sells $136k in stock By Investing.com - Investing.com Nigeria
Natera: President Fesko sells $105k in shares By Investing.com - Investing.com Canada
Natera: President Fesko sells $105k in shares - Investing.com
Natera president sells $136k in stock - Investing.com
Natera Surges 2.89% on $240M Volume as Institutional Buyers Pile In Stock Ranks 423rd in Market Activity Amid Analyst Upgrades - AInvest
LabCorp Fails to Block Natera Patent-Invalidity Claims Pre-Trial - Bloomberg Law News
Can Natera Inc. Regain Momentum After Breakdown2025 Winners & Losers & Advanced Technical Analysis Signals - beatles.ru
Natera’s Strong Growth Potential and Market Leadership Justify Buy Rating - TipRanks
Natera Inc. Pullback Analyzed — Is It Time to ExitJuly 2025 EndofMonth & Fast Entry Momentum Trade Alerts - sundaytimes.kr
Non-invasive Prenatal Testing Market Set to Witness Massive - openPR.com
Natera price target raised to $195 from $185 at Morgan Stanley - MSN
Compared to Estimates, Natera (NTRA) Q2 Earnings: A Look at Key Metrics - MSN
5 Revealing Analyst Questions From Natera’s Q2 Earnings Call - Yahoo Finance
Natera (NTRA) Q2 Results: 32% Revenue Growth, Strong Buy RatingNews and Statistics - IndexBox
Natera Q2 Earnings Call Highlights Strong Growth, Raises Revenue Guidance and Announces New Product Launches and Innovations - AInvest
1 ‘Strong Buy’ Stock Analysts Think Will Soar 62% - Yahoo Finance
Natera (NTRA) Is Up 14.1% After Raising Revenue Guidance and Launching New Prenatal Test – Has the Bull Case Changed? - simplywall.st
Natera Insider Sold Shares Worth $958,059, According to a Recent SEC Filing - MarketScreener
Natera director Sheena Jonathan sells $958k in NTRA stock - Investing.com
Natera director Sheena Jonathan sells $958k in NTRA stock By Investing.com - Investing.com Australia
Natera Inc. Reports Strong Growth and Strategic Advances - TipRanks
Natera at Canaccord Conference: Growth and Innovation in Focus - Investing.com
Natera at Canaccord Conference: Growth and Innovation in Focus By Investing.com - Investing.com Australia
Natera Surges 1.76% on $290M Volume, Climbs to 356th in Market Activity - AInvest
How clinicogenomic data are reshaping kidney disease trials and drug discovery - Nature
New noninvasive prenatal test can screen for CF, other genetic diseases - Cystic Fibrosis News Today
Leerink Partners Maintains Natera(NTRA.US) With Buy Rating, Announces Target Price $235 - 富途牛牛
NTRA Q2 Deep Dive: Oncology Growth, Product Innovation, and Margin Pressures - TradingView
Natera Surges 3.35% as Daily Volume Slumps 49.12% to 310M Dollar Ranking 335th in Market Activity - AInvest
Natera Stock Jumps 13.69% In 3 Days As Technicals Signal Bullish Reversal - AInvest
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Cytek Biosciences (CTKB), Natera (NTRA) and Warby Parker (WRBY) - The Globe and Mail
Natera: Piper Sandler Raises PT to $220 from $210, Maintains Overweight - AInvest
Natera And 2 Other Stocks That May Be Priced Below Their Estimated Value - Yahoo Finance
Natera (NTRA) Reports Q2 Loss, Tops Revenue Estimates - MSN
Mixed Analyst Opinions on Healthcare Stocks Cytek Biosciences, Natera, and Warby Parker - AInvest
Natera introduces prenatal test for detecting inherited conditions - MSN
Natera raises revenue guidance to $2.1B and targets margin expansion through AI-driven efficiencies - MSN
Evercore Gives Natera (NTRA) Outperform Rating - MSN
Natera's Signatera test to be covered under Medicare - MSN
How much upside does Natera Inc. haveAnalyst Upgrade Watch - thegnnews.com
What is the Moat Score of Natera Inc.Free Growth Stock Screener - mustnews.co.kr
Natera Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Natera, Inc. (NASDAQ:NTRA) Q2 2025 Earnings Call Transcript - Insider Monkey
What technical models suggest about Natera Inc.’s comebackFree Secure Capital Picks With Upside Potential - Newser
14 Best Aggressive Growth Stocks to Buy According to Analysts - Insider Monkey
Natera shares surge 17% after strong Q2 results and upgraded guidance - Invezz
Natera Stock: Growth or Bubble? - StocksToTrade
Natera Inc. Stocks Soar After Impressive Q2 Results - timothysykes.com
Natera’s Stock Leaps Amid Clinical Trial Success - StocksToTrade
Natera (NTRA) Shares Surge on Q2 Outperformance: Is This a Sustainable Growth Story or a Short-Term Overreaction? - AInvest
Natera price target raised to $200 from $194 at Baird - TipRanks
Why Are Natera (NTRA) Shares Soaring Today - TradingView
Natera Gets First Nod for $8.25 Million Prenatal Test Settlement - Bloomberg Law News
Natera (NTRA) Is Up 5.6% After Raising Revenue Outlook and Launching New Prenatal Test - simplywall.st
Natera’s Latest Achievements Elevate Prospects Post-World Transplant Congress - timothysykes.com
Natera Stock (NTRA) Soars 14% on Strong Financial Results - TipRanks
Natera’s Strong Growth and Strategic Advancements Justify Buy Rating - TipRanks
0.32%
0.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):